Evidence map›Paper›PMID 27707755›Full record

ArticleEMBO molecular medicine2016

Constitutive activation of DIA1 (DIAPH1) via C-terminal truncation causes human sensorineural hearing loss.

Takehiko Ueyama, Yuzuru Ninoyu, Shin-Ya Nishio, Takushi Miyoshi, Hiroko Torii, Koji Nishimura, Kazuma Sugahara, Hideaki Sakata, Dean Thumkeo, Hirofumi Sakaguchi and 4 more

Open access · goldAbstract read
In one paragraph

Article in EMBO molecular medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Cochlear Implantation Outcomes in Genotyped Subjects with Sensorineural Hearing Loss.Journal of the Association for Research in Otolaryngology : JARO · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Dispensable role of Rac1 and Rac3 after cochlear hair cell specification.Journal of molecular medicine (Berlin, Germany) · 2023
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 1 country.

Takehiko UeyamaLaboratory of Molecular Pharmacology, Biosignal Research Center, Kobe University, Kobe, Japan tueyama@kobe-u.ac.jp kitajiri@ent.kuhp.kyoto-u.ac.jp.ORCID 0000-0002-5647-3937
Yuzuru NinoyuLaboratory of Molecular Pharmacology, Biosignal Research Center, Kobe University, Kobe, Japan.ORCID 0000-0002-9407-4697
Shin-Ya NishioDepartment of Otorhinolaryngology, Shinshu University School of Medicine, Matsumoto, Japan.
Takushi MiyoshiDepartment of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Hiroko ToriiDepartment of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Koji NishimuraDepartment of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Kazuma SugaharaDepartment of Otolaryngology, Yamaguchi University Graduate School of Medicine, Ube, Japan.
Hideaki SakataKawagoe Otology Institute, Kawagoe, Japan.
Dean ThumkeoMedical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Hirofumi SakaguchiDepartment of Otolaryngology-Head and Neck Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Naoki WatanabeDepartment of Pharmacology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Shin-Ichi UsamiDepartment of Otorhinolaryngology, Shinshu University School of Medicine, Matsumoto, Japan.
Naoaki SaitoLaboratory of Molecular Pharmacology, Biosignal Research Center, Kobe University, Kobe, Japan.
Shin-Ichiro KitajiriDepartment of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan tueyama@kobe-u.ac.jp kitajiri@ent.kuhp.kyoto-u.ac.jp.
Kyoto University · JPKobe University · JPShinshu University · JPKawagoe Technical High School · JPKyoto Prefectural University · JPYamaguchi University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DIAPH1 encodes human DIA1, a formin protein that elongates unbranched actin. The c.3634+1G>T DIAPH1 mutation causes autosomal dominant nonsyndromic sensorineural hearing loss, DFNA1, characterized by progressive deafness starting in childhood. The mutation occurs near the C-terminus of the diaphanous autoregulatory domain (DAD) of DIA1, which interacts with its N-terminal diaphanous inhibitory domain (DID), and may engender constitutive activation of DIA1. However, the underlying pathogenesis that causes DFNA1 is unclear. We describe a novel patient-derived DIAPH1 mutation (c.3610C>T) in two unrelated families, which results in early termination prior to a basic amino acid motif (RRKR

Indexed as

Gene Expression RegulationAdaptor Proteins, Signal TransducingAnimalsChildDisease Models, AnimalFemaleForminsHearing Loss, SensorineuralHumansMiceMice, TransgenicMiddle AgedSequence Analysis, DNAAdaptor Proteins, Signal TransducingDIAPH1 protein, humanForminsactindeafnessDFNA1DIAPH1stereocilia

Identifiers

PMID27707755
PMCPMC5090661
OpenAlexW2529045253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.